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Background: Both anaemia and high haemoglobin in pregnancy are 
associated with adverse pregnancy outcomes including foetal growth 
restriction. The objective of this study was to investigate the 
associations between maternal haemoglobin in pregnancy and 
trajectories of length/height and weight from birth through 
childhood. 
Methods: Data from 7,597 singleton pregnancies in the Avon 
Longitudinal Study of Parents and Children (ALSPAC), an ongoing, 
prospective, UK population-based pregnancy cohort study were used. 
We examined associations between maternal haemoglobin (overall 
pregnancy and trimester specific) and offspring length and weight at 
birth, as well as trajectories of height and weight gain from birth to 
age 10 years derived from multilevel models. 
Results: Mean pregnancy haemoglobin was 11.61 g/dL (SD 1.12). For 
each 1g/dL higher mean overall pregnancy haemoglobin, offspring 
were on average -0.30 cm shorter (95%CI: -0.35, -0.24, p <0.001), and -
97.7 g lighter (95%CI: -110.42, -84.93, p <0.001) at birth when 
adjusting for potential confounders. Trimester specific inverse 
associations with birth length and weight were strongest for third 
trimester haemoglobin. There was evidence of a positive association 
between maternal haemoglobin levels and offspring height gain up to 
the age of one year and no strong evidence of associations between 
pregnancy haemoglobin and childhood weight gain. 
Conclusions: In high income countries, higher maternal haemoglobin 
in pregnancy may be a concern, as well as anaemia. Further studies 
are needed to define ‘high’ haemoglobin in pregnancy and whether 
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monitoring of women with high pregnancy haemoglobin is warranted.
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Introduction
The estimated prevalence of anaemia among pregnant women 
is around 38% worldwide1 and is considered to be a ‘moder-
ate’ public health problem by the World Health Organisation 
(WHO)2. In the UK, anaemia, most commonly reflecting iron 
deficiency anaemia (IDA)3 affects some 15% of pregnancies.
There is evidence that maternal anaemia in pregnancy is 
associated with adverse pregnancy outcomes including low 
birthweight, increased risk of pre-term delivery4–6, small-for-
gestational-age babies, perinatal IDA7 and foetal distress8 and 
stillbirth9,10. Furthermore, while infants born at term at a normal 
birth weight have adequate iron stores for the first few months 
of life11, it has been shown that infants of mothers who have 
low iron stores in pregnancy are more likely to develop 
anaemia7,12. While most recent research has focussed on the 
potential adverse effects of low haemoglobin in pregnancy, 
there is also evidence that higher levels of haemoglobin, 
haematocrit, and ferritin are associated with poor pregnancy 
outcomes including stillbirth, foetal growth restriction, pre- 
term delivery, and preeclampsia4,5,13–19.
To the best of our knowledge, the association of maternal hae-
moglobin during pregnancy with offspring growth in childhood 
has not previously been studied. In this study, we examine the 
associations of maternal haemoglobin in pregnancy with off-
spring length and weight at birth, and subsequent growth up 
to the age of 10 years using data from a large, population based 
prospective pregnancy cohort in a high-income country setting.
Methods
Ethical statement
Ethical approval for the study was obtained from the ALSPAC 
Law and Ethics Committee and the Local Research Ethics 
Committees (project approval number B1107). Consent for 
biological samples has been collected in accordance with the 
Human Tissue Act (2004). Informed consent for the use of 
data collected via questionnaires and clinics was obtained 
from participants following the recommendations of the 
ALSPAC Ethics and Law Committee at the time (listed at 
http://www.bristol.ac.uk/alspac/researchers/research-ethics/).
Study population
The Avon Longitudinal Study of Parents and Children (ALSPAC) 
is an ongoing, prospective, population-based, pregnancy cohort 
study. Pregnant women resident in Avon, UK with expected 
dates of delivery 1st April 1991 to 31st December 1992 were 
invited to take part in the study. The initial number of pregnan-
cies enrolled was 14,541. Of these pregnancies, 14,273 singleton 
pregnancies were followed up resulting in 13,617 singleton live 
born offspring who survived to at least one year of age. 7,957 
of these mother-child pairs had complete data included in our 
analysis. Further details of this cohort study have been described 
in detail previously20,21. Please note that the study website con-
tains details of all the data that is available through a fully 
searchable data dictionary and variable search tool at: http://
www.bristol.ac.uk/alspac/researchers/our-data/. Figure 1 shows 
the participants flow-chart for the present study.
Maternal haemoglobin in pregnancy
Values of all routinely measured haemoglobin in pregnancy (in 
g/dL) were extracted from antenatal medical records. Women 
had between one and 20 haemoglobin measurements with a 
mode of three measurements (mean 3.36) across the preg-
nancy. Mean haemoglobin values were calculated for each 
woman with more than one measurement across: i) the entire 
pregnancy; and ii) for each trimester. Trimesters were defined 
as: first trimester (<13 completed weeks of gestation), second 
(≥13 weeks to <26 weeks) and third (≥26 weeks).
Offspring length and weight at birth and during 
childhood
Birth length (crown to heel length) was measured by ALSPAC 
staff who visited newborns soon after birth (median 1 day, 
range 1–14 days) using a Harpenden neonatometer (Holtain 
Ltd)22. Subsequent height data for the children were obtained 
from health visitor records, parental reports and measure-
ments taken at clinic visits, as previously described23. Birth 
weight was extracted from medical records and up to four fur-
ther weight measurements were taken from routine health visi-
tor records (as part of standard UK childcare) at around two, 
10, 21 and 48 months. Additionally, mothers were asked to 
report their child’s height and weight regularly from three years, 
and clinics were carried out at seven, eight, nine, and 10 years 
for all participants and at four, eight, 12 and 18 months for a 
subset of 10% of participants. Height and weight measures 
that were self-reported by parents were coded with a ‘self-
report’ flag. Previous research has demonstrated that the accu-
racy of measurements varies between clinical and parent-reported 
measurements but that measurements from research clinics 
and routine child healthcare records have similar accuracy23,24.
Other measures
Maternal age (in years) at the start of the pregnancy, mater-
nal ethnicity (as a binary variable - white, non-white), parity 
(as a binary variable describing ≤2 pregnancies including the 
study pregnancy or >2 pregnancies), and maternal height were 
all obtained from self-reported questionnaires completed by 
the mother. Maternal pre-pregnancy body mass index (BMI) 
was derived from pre-pregnancy weight self-reported by the 
mother and their self-reported height. Maternal smoking in 
pregnancy, categorised as “None”, “Temporary” and “Through-
out”, was based on self-report. Household social class was 
allocated using the highest parental occupation as self- 
reported by the mother according to the 1991 British Office 
of Population and Census Statistics (OPCS) classification. 
Offspring gender (as a binary variable) was obtained from 
medical records. Gestational age at delivery was based on last 
menstrual period (LMP) when the mother was certain of this, 
for uncertain LMPs and conflicts with clinical assessment the 
ultrasound assessment was used. Where maternal report and 
ultrasound assessment conflicted, an experienced obstetrician 
reviewed clinical records and made a best estimate.
Statistical analysis
Offspring growth trajectories were previously estimated using 
multilevel linear spline models25. Multilevel models permit 
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Figure 1. Inclusion/exclusion flowchart.
individual variation in growth trajectories with random effects 
allowing each individual participant to have person-specific 
intercepts and slopes. Models had two levels, with measure-
ment occasions at level 1 nested within individuals at level 
2. Knot points were placed at three months, one year, three 
years and 10 years for height and three months, one year, 
seven years and 10 years for weight; with linear changes in 
growth assumed between these ages, as previously described25.
Here, we ran spline models including maternal pregnancy 
haemoglobin (overall pregnancy mean, trimester specific mean) 
as an independent variable in both unadjusted and a confounder 
adjusted models. We considered the following to be potential 
confounders: source of height/weight measurement, gender, 
maternal age, pre-pregnancy BMI and height, length of ges-
tation, ethnicity, maternal pregnancy smoking status, parity, 
and household social class. To ensure comparability between 
unadjusted and adjusted models, only those pregnancies with 
all available covariables were considered in the unadjusted 
model as well as in the adjusted model.
We tested for departure from a linear relationship between 
maternal overall pregnancy haemoglobin and offspring 
growth by comparing a model in which quintiles of maternal 
haemoglobin was entered as a continuous versus four dummy 
variables.
Participants included in our analysis were compared with 
participants of the ALSPAC cohort who were excluded 
from our analysis due to missing data. We compared them 
in terms of household social class, maternal height, weight, 
ethnicity, smoking status and age, and pregnancy gestation 
length, parity and mean Hb using t-tests to compare means for 
continuous data and chi2-tests to compare frequency distributions 
as appropriate.
Data were analysed using Stata Version 13 (StataCorp, College 
Station, TX, USA) with the MLwiN (version 2.36) multilevel 
modelling plug-in tool ‘runmlwin’26.
Results
A total of 7957 singleton pregnancies were included in the 
analyses of overall pregnancy mean haemoglobin. Figure 1 
shows the participant flow chart. Mean overall pregnancy 
haemoglobin was 11.61 g/dL (SD 1.12). Trimester specific 
means were: 12.53 g/dL (SD 0.89; N=5786) for the first 
trimester, 11.90 g/dL (SD 1.04, N=2011) for the second, and 
11.28 g/dL (SD 0.86, N=7512) for the third. 
Mothers excluded from analyses due to missing data were 
shorter, more likely to smoke in pregnancy, to be of non-white 
ethnic origin, to be multiparous and to deliver prematurely. 
Finally, mean pregnancy haemoglobin in excluded pregnancies 
was lower in excluded women, but only marginally (Table 1).
There was no evidence for departure from a linear relation-
ship between maternal pregnancy haemoglobin and offspring 
outcomes.
Height
For each 1g/dL higher mean overall pregnancy haemo-
globin, offspring were on average 0.30 cm shorter at birth 
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(95%CI -0.35, -0.24, p <0.001), when adjusting for potential 
confounders (Table 2). Maternal overall pregnancy haemoglobin 
was positively associated with offspring linear growth between the 
ages of 0-3 months and 3-12 months in both the unadjusted and 
adjusted models, so that differences in birth length did not 
persist beyond the age of 12 months. There was no strong 
evidence of associations with growth beyond the first year. 
Similar associations were noted when each trimester was ana-
lysed separately, with the largest association with birth length 
observed for trimester 3 (mean difference in birth length 
-0.36 cm; 95%CI: -0.41, -0.30; Table 3).
Weight
For each 1g/dL higher mean overall pregnancy haemoglobin, 
offspring were on average -97.7g lighter at birth (95% CI -
110.42g to -84.93g, p <0.001), when adjusting for potential 
confounders (Table 4). Overall pregnancy haemoglobin was 
positively associated with offspring weight gain between the 
ages of 3–12 months and 7–10 years in the unadjusted model 
(p <0.001), but in the adjusted model only the association 
with weight gain between 3–12 months remained. By the age 
of 12 months the mean difference was less than 40g (calcu-
lated by summing the effect estimates for birth weight and 
Table 1. Characteristics of mothers included and excluded from analyses.
Participants included in 
our analysis
Participants 
excluded from our 
analysis
p-value
No. % No. %
Gender 7957 5565 0.10
Female 3900 49.0 2647 33.3
Ethnicity 7957 3998 <0.01
Non-white 135 1.7 173 4.3
Household social class 7957 1285 <0.01
i 1235 15.5 144 11.2
ii 3597 45.2 546 42.5
iiinm 2183 27.4 370 28.8
iiim 700 8.8 175 13.6
iv/v 242 3.0 50 3.9
Maternal smoking during 
pregnancy
7957 4738 <0.01
Never 6367 80.0 3095 65.3
Temporary/Some 459 5.8 419 8.8
Throughout 1131 14.2 1224 25.8
Parity 7957 4785 <0.01
≤2 pregnancies 7658 96.2 4345 90.8
No. Mean (SD) No. Mean (SD)
Maternal height (cm) 7957 164.21 (6.66) 3894 163.43 (6.84) <0.01
Maternal BMI (kg/m2) 7957 22.91 (3.72) 3239 23.02 (4.19) 0.19
Maternal age (years) 7957 28.68 (4.58) 5565 26.94 (5.33) <0.01
Gestation (weeks) 7957 39.54 (1.68) 5565 39.39 (2.04) <0.01
Mean pregnancy Hb (g/dL) 7957 11.72 (0.80) 4891 11.61 (0.87) <0.01
BMI, body mass index; Hb, haemoglobin; SD, standard deviation.
Page 5 of 13
Wellcome Open Research 2020, 5:236 Last updated: 19 OCT 2020
Table 3. Trimester specific associations between maternal pregnancy haemoglobin (g/dL) and birth length and height 
gain*.
1st trimester 2nd trimester 3rd trimester
N = 5786 N = 2011 N = 7512
Mean 
diff.
95% CI p value Mean 
diff.
95% CI p value Mean 
diff.
95% CI p value
Birth length (cm) -0.07 (-0.13, 0.003) 0.04 -0.15 (-0.23, -0.06) <0.001 -0.36 (-0.41, -0.30) <0.001
Height gain from 0–3 
months (cm/year)
0.07 (-0.21, 0.34) 0.63 0.15 (-0.25, 0.54) 0.47 0.28 (0.04, 0.53) 0.02
Height gain from 3–12 
months (cm/year)
-0.03 (-0.22, 0.16) 0.76 -0.05 (-0.35, 0.25) 0.75 0.24 (0.07, 0.42) 0.01
Height gain from 1–3 
years (cm/year)
0.03 (-0.02, 0.09) 0.23 0.06 (-0.02, 0.14) 0.16 -0.02 (-0.07, 0.03) 0.52
Height gain from 3–10 
years (cm/year)
0.003 (-0.02, 0.02) 0.82 -0.03 (-0.06, 0.003) 0.08 0.01 (-0.01, 0.03) 0.33
* Results are from the confounder adjusted model that includes: source of measurement, gender, maternal BMI, maternal height, maternal age, 
gestation, ethnicity, maternal pregnancy smoking status, parity, household social class.
BMI, body mass index; CI, confidence interval.
Table 2. Associations between mean overall pregnancy haemoglobin (g/dL) and birth length and 
height change.
Model 1 Model 2
N = 7957 Mean 
diff.
95% CI p value Mean diff. 95% CI p value
Birth length difference (cm) -0.22 (-0.27, -0.16) <0.001 -0.30 (-0.36, -0.24) <0.001
Change in height from 0–3 
months (cm/year)
0.25 (0.04, 0.46) 0.02 0.25 (0.001, 0.51) 0.05
Change in height from 3–12 
months (cm/year)
0.24 (0.09, 0.39) 0.002 0.17 (-0.01, 0.35) 0.07
Change in height from 1–3 
years (cm/year)
0.003 (-0.04, 0.05) 0.86 -0.01 (-0.06, 0.05) 0.84
Change in height from 3–10 
years (cm/year)
0.02 (0.01, 0.04) 0.01 0.01 (-0.01, 0.03) 0.57
Model 1 – unadjusted.
Model 2 – adjusted for confounders; source of measurement, gender, maternal BMI, maternal height, maternal age, 
gestational age at delivery, ethnicity, maternal pregnancy smoking status, parity, household social class.
BMI, body mass index; CI, confidence interval.
weight gain 0–3 and 2–12 months). When we examined each 
trimester separately (Table 5), mean maternal haemoglobin in 
each trimester was negatively associated with birth weight; the 
largest effect was observed for the third trimester: for each 
1g/dL higher haemoglobin, offspring were on average -112.0 
g lighter at birth (95% CI -124.27g to -99.68g, p <0.001), 
when adjusting for potential confounders.
Sensitivity analyses
In analyses excluding all women with mean pregnancy 
haemoglobin >2 standard deviations away from the mean 
(outside 10.07 to 13.3 g/dL), results for both height and weight 
were largely unchanged, suggesting that associations are not 
driven by extreme values of pregnancy haemoglobin.
We repeated analyses using multiple linear regression using 
observed birth length and weight data (as opposed to predicted 
values from the multilevel model used in the main analysis. 
These showed similar associations to the main results: a 1g/dL 
increase in mean haemoglobin was associated with a 0.31 cm 
lower birth length (95%CI -0.37 to -0.25cm, p<0.001; N=6196 
pregnancies) and a 101g lower birth weight (95%CI -114 
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Table 5. Trimester specific associations between maternal pregnancy haemoglobin (g/dL) and birth length and childhood 
height gain*.
Change of 1g/dL mean Hb in first 
trimester
Change of 1g/dL mean Hb in 
second trimester
Change of 1g/dL mean Hb in third 
trimester
N = 5784 N = 2011 N = 7510
Change 95% CI p value Change 95% CI p value Change 95% CI p value
Change in birth 
weight (g)










60.75 (1.36, 120.14) 0.05 50.17 (-35.05, 135.40) 0.25 55.78 (2.24, 109.32) 0.04
Change in 
weight from 
1–7 years  
(g/year)





12.21 (-50.31, 74.74) 0.70 -82.24 (-172.27, 7.79) 0.07 27.03 (-29.79, 83.85) 0.35
* Results are from the confounder adjusted model that includes: source of measurement, gender, maternal BMI, maternal height, maternal age, gestation, 
ethnicity, maternal pregnancy smoking status, parity, household social class.
BMI, body mass index; CI, confidence interval; Hb, heomoglobin.
Table 4. Associations between mean overall pregnancy haemoglobin (g/dL) and birth weight and 
childhood weight gain.
Model 1 Model 2
N = 7954 Mean 
diff.
95% CI p value Mean 
diff.
95% CI p value
Birth weight (g) -68.04 (-79.80, -56.27) <0.001 -97.67 (-110.42, -84.93) <0.001
Weight gain from 0–3 months 
(g/year)
47.07 (-13.81, 107.94) 0.13 39.32 (-32.58, 111.23) 0.28
Weight gain from 3–12 months 
(g/year)
91.35 (46.26, 136.44) <0.001 66.79 (11.35, 122.23) 0.02
Weight gain from 1–7 years 
(g/year)
5.41 (-6.85, 17.68) 0.39 -9.57 (-24.42, 5.28) 0.21
Weight gain from 7–10 years 
(g/year)
102.14 (50.87, 153.40) <0.001 25.69 (-32.67, 84.05) 0.86
Model 1 – unadjusted.
Model 2 – adjusted for confounders: source of measurement, gender, maternal BMI, maternal height, maternal age, gestational 
age at delivery, ethnicity, maternal pregnancy smoking status, parity, household social class.
BMI, body mass index; CI, confidence interval.
to -88g, p<0.001; N=6092 pregnancies) when adjusted for 
confounders. Finally, results did not substantially change 
when analyses were restricted to mother-offspring pairs with 
haemoglobin measures in all three trimesters (N=507).
Discussion
In this study, we found that both overall and trimester spe-
cific mean maternal pregnancy haemoglobin were inversely 
associated with offspring birth length and weight in a 
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general population sample of British women. These asso-
ciations were most pronounced for haemoglobin in the third 
trimester compared to the first and second trimester. However, 
these differences did not persist into childhood. 
Our results for birth weight and length are in line with sev-
eral reports based on large samples from international 
studies. A large (n= 153,602) UK retrospective cohort study 
found that the heaviest babies were born to women with lower 
haemoglobin: 85 to 95 g/dL when compared to other haemo-
globin bands from ≤85 through to >14513. Another UK study 
found that both low (defined as <10.4 g/dL) and high haemo-
globin (>13.2 g/dL) in early pregnancy were associated with 
adverse pregnancy outcomes including perinatal death, pre-
term delivery, and low birthweight14. Studies in the US have 
shown that higher pregnancy haemoglobin is associated with 
adverse outcomes such as foetal growth retardation15 and small-
for-gestational-age babies16. Additionally, a large (n=10,340 
women) Chinese study found that a low (<130g/dL) second tri-
mester haemoglobin, when coupled with a high (>130 g/dL) 
haemoglobin in the third trimester increased the risk of pre-
term birth27. Finally, in the Generation R study, elevated 
haemoglobin levels (≥13.2 g/dl) were associated with foetal 
head circumference, length, and weight growth restriction from 
the third trimester onwards, as well as low birth weight and 
small-for-gestational-age babies, and hypertensive disorders of 
pregnancy and preterm delivery28.
Despite this evidence, there is a focus on the potential adverse 
effects of lower pregnancy haemoglobin levels and on assess-
ing the benefits of supplementation29–32. The rationale for this in 
low- and middle-income countries (LMICs) where undernutri-
tion is highly prevalent is understandable, but in high income 
countries, our own and other results suggest that it is higher 
haemoglobin that is associated with suboptimal foetal growth.
Maternal blood volume increases by approximately 1.5 litres 
during pregnancy33 and red cell mass also increases but to 
a lesser degree compared to the increase in plasma volume, 
resulting in a dilutional anaemia34. It has been previously pos-
ited that this drop in blood osmolality in pregnancy due to 
plasma dilution would result in reduced blood viscosity; this in 
turn enhances blood flow in the low pressure intervillous space 
and thus promotes foetal growth18. Conversely, a pathologi-
cal lack of plasma dilution during pregnancy might result in 
poorer foetal growth. Therefore, in well-nourished populations, 
higher maternal haemoglobin levels in pregnancy may reflect 
impaired haemodilution resulting in reduced foetal growth. 
An alternative explanation may be that larger foetuses place 
greater demands on maternal resources, potentially causing lower 
maternal haemoglobin.
There is no consensus as to threshold values for normal (and 
thus abnormal) haemoglobin across the different stages of 
pregnancy. The World Health Organisation1 defines anaemia 
in pregnancy to be <11.0 g/dL and accounts for smoking and 
altitude when providing prevalence estimates but it does not 
define an upper limit of normal haemoglobin in pregnancy. UK 
National Institute for Clinical and Health Excellence (NICE)35 
also considers a pregnancy haemoglobin value <11.0 g/dL 
to be abnormal ‘at first contact’, and lowers the threshold to 
<10.5 g/dL at 28 weeks gestation, but no upper normal values 
are specified. A review of publications of laboratory values in 
pregnancy found five studies that provided normal haemo-
globin reference ranges (2.5 percentile to 97.5 percentile). These 
were 11.6-13.9 g/dL in first trimester, 9.7-14.8 g/dL in second 
trimester and 9.5-15.0 g/dL in third trimester36.
Future studies of haemoglobin and other iron indices in preg-
nancy and their relation to pregnancy outcomes in high income 
settings could be useful in establishing whether maternal 
haemoglobin, which is routinely measured, may be an inex-
pensive and useful biomarker for detecting pregnancies at risk 
for suboptimal foetal growth that may benefit from further 
assessment.
Our study has both strengths and limitations. Strengths include 
its prospective design, large sample size, the availability of mul-
tiple measures of both haemoglobin across pregnancy and of 
offspring height and weight as well as data on multiple poten-
tial confounders. However, we did not have data on other indi-
ces of iron deficiency such as ferritin and haematocrit that 
would have enabled better characterisation of anaemia by type. 
Moreover, information on haematinics would have allowed 
us to examine the ratio of the red blood cell volume to plasma 
volume to assess and account for physiological plasma dilution.
In conclusion, higher maternal pregnancy haemoglobin is asso-
ciated with lower offspring birth length and weight of the 
infant; but these differences do not persist across childhood. 
High maternal haemoglobin in pregnancy may be a biomarker 
of impaired haemodilution. Further studies examining the pre-
dictive value of maternal pregnancy haemoglobin in relation to 
foetal growth restriction are warranted.
Data availability
ALSPAC encourage data sharing to maximise use of the 
resource, so the executive may put researchers in touch with 
other groups working in the same area. Most of the data are 
available for use on request and for these data that are not 
considered of overlap. The identical dataset for this project can 
be obtained with the unique project approval number: B1107.
ALSPAC data access is through a system of managed open 
access. The steps below highlight how to apply for access to 
the data included in this data note and all other ALSPAC data:
1.    Please read the ALSPAC access policy (http://www.
bristol.ac.uk/media-library/sites/alspac/documents/
researchers/data-access/ALSPAC_Access_Policy.pdf) 
which describes the process of accessing the data and 
samples in detail, and outlines the costs associated with 
doing so.
2.    You may also find it useful to browse our fully searchable 
research proposals database (https://proposals.epi.bristol.
ac.uk/?q=proposalSummaries), which lists all research 
projects that have been approved since April 2011.
3.    Please submit your research proposal (https://proposals.
epi.bristol.ac.uk/) for consideration by the ALSPAC 
Executive Committee. You will receive a response within 
10 working days to advise you whether your proposal 
has been approved.
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If you have any questions about accessing data, please email 
alspac-data@bristol.ac.uk.
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Tom Norris   
School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK 
I enjoyed reading the manuscript, which documents the association between maternal 
haemoglobin during pregnancy and growth in infancy and childhood.  
 
The authors investigated continuous Hb levels across gestation and the association with weight 
and length at birth and then subsequent growth trajectories across infancy and childhood (up to 
10 years). They observed an inverse association between Hb levels and size and birth, such that 
higher Hb levels were associated with a smaller birth length and lower birth weight. Thereafter, 
they observed an increased growth rate in length between 0-3 months and 3-12 months and 
weight change between 3-12 months. However, the strength of evidence for the association 
between Hb levels and growth, both linear and weight growth, was weak.  
 
I have more specific comments below, split into the sections in which they apply. 
 
Methods:
Study population (page 3): Did all dyads have to have all three Hb. 
 
○
Maternal haemoglobin in pregnancy (page 3): The authors state that the range of Hb 
measurements in the sample was 1-20 and i was wondering if the authors had considered 
the reasons why a woman would need such a high amount of Hb measurements. Does this 
increased surveillance signify a higher risk pregnancy, which should be acknowledged 
accordingly. I believe current UK guidelines are for two Hb measurements over the course 
of pregnancy, so the fact that a lot of women in the sample have had some increased 




Offspring weight and length data (page 3): The authors acknowledge that their is varying 
accuracy in measurements taken in different settings and if measured vs self-report. 
However, did they incorporate this into the growth models, i.e. did they model the level-1 
error according to whether data were measured vs self report? 
○
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Can the authors provide a breakdown of the sweeps and the number of participants 
attending each sweep as a supplementary table. This can help identify whether the chosen 
growth model is suitable for the data and the number of sweeps (i.e. not overfitting). 
 
○
Other measures (page 3): 'sex' and not 'gender'? 
 
○
Statistical analysis (page 4): How were knot points chosen (both number and location)? 
 
○
What was the variance/covariance structure assumed to be, e.g. covar between birth 
measurements and measurements in infancy? 
 
○
I am not sure about the use of the term confounders for some of these variables. For 
example, using the traditional definition of confounder, does source of measurement 
predict both maternal Hb and growth? The same can be asked of offspring gender, length 
of gestation, parity and perhaps some of the others? If however, these have been identified 
as confounders because they close the backdoor path between Hb and growth, then i think 




The second trimester sample size was much smaller than the first and third? Is this because 
routine testing is generally in first and third trimesters in UK? Is the sample therefore 
including a high proportion of women deemed at 'higher risk' (i.e., as they have more 
intensive monitoring in pregnancy?). It appears the 3rd trimester Hb data is based on a 
much larger sample than even the first, which is surprising? Do the authors have any 
suggestion as to why this might be? 
 
○
Table 1 (page 5): can the authors provide a footnote for social class levels 
 
○
Height and weight associations (page 5 and tables 2 and 4): In general i think the strength 
of evidence is not particularly strong for the association between Hb levels and growth in 
both length and weight and i think this should be emphasised in the results and discussion.  
 
○
Weight (page 5): i know gestational age is included in the model as a confounder, but given 
that this is likely not a confounder in the true meaning of the word, did the authors consider 
using a birth weight outcome variable which was inherently adjusted for gest age, i.e., bwt 
z-score? This may well complicate the analysis though, as the infant/child outcomes are on 
the raw scale, not z-scores. 
 
○
Tables 2,3: There are instances where the number of decimal places is not consistent in the 
confidence intervals and I think this may have been done to illustrate that the intervals are 
not including the null. I think the number of decimal places should be the same throughout. 
Additionally can the authors please check the CI and p-value for the estimate for birth 




Is the work clearly and accurately presented and does it cite the current literature?
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Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
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expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
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